BOHMOVA, Jana, Marek LUBUSKY, Iva HOLUSKOVA, Martina STUDNICKOVA, Romana KRATOCHVILOVA, Eva KREJCIRIKOVA, Veronika DURDOVA, Tereza KRATOCHVILOVA, Ladislav DUŠEK, Martin PROCHAZKA a Radek VODICKA. Two Reliable Methodical Approaches for Non-Invasive RHD Genotyping of a Fetus from Maternal Plasma. Diagnostics. Basel: MDPI, 2020, roč. 10, č. 8, s. 1-15. ISSN 2075-4418. Dostupné z: https://dx.doi.org/10.3390/diagnostics10080564.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Two Reliable Methodical Approaches for Non-Invasive RHD Genotyping of a Fetus from Maternal Plasma
Autoři BOHMOVA, Jana (203 Česká republika), Marek LUBUSKY (203 Česká republika), Iva HOLUSKOVA (203 Česká republika), Martina STUDNICKOVA (203 Česká republika), Romana KRATOCHVILOVA (203 Česká republika), Eva KREJCIRIKOVA (203 Česká republika), Veronika DURDOVA (203 Česká republika), Tereza KRATOCHVILOVA (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí), Martin PROCHAZKA (203 Česká republika) a Radek VODICKA (203 Česká republika, garant).
Vydání Diagnostics, Basel, MDPI, 2020, 2075-4418.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30218 General and internal medicine
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.706
Kód RIV RIV/00216224:14110/20:00116484
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/diagnostics10080564
UT WoS 000568020600001
Klíčová slova anglicky non-invasive fetal genotyping; RHDgene; cell-free fetal DNA; real-time PCR; QF PCR; Rh blood group system; red blood cell alloimmunization; hemolytic disease of the fetus and newborn
Štítky 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 24. 9. 2020 07:08.
Anotace
Noninvasive fetalRHDgenotyping is an important tool for predicting RhD incompatibility between a pregnant woman and a fetus. This study aimed to assess a methodological approach other than the commonly used one for noninvasive fetalRHDgenotyping on a representative set of RhD-negative pregnant women. The methodology must be accurate, reliable, and broadly available for implementation into routine clinical practice. A total of 337 RhD-negative pregnant women from the Czech Republic region were tested in this study. The fetalRHDgenotype was assessed using two methods: real-time PCR and endpoint quantitative fluorescent (QF) PCR. We used exon-7-specific primers from theRHDgene, along with internal controls. Plasma samples were analyzed and measured in four/two parallel reactions to determine the accuracy of theRHDgenotyping. TheRHDgenotype was verified using DNA analysis from a newborn buccal swab. Both methods showed an excellent ability to predict theRHDgenotype. Real-time PCR achieved its greatest accuracy of 98.6% (97.1% sensitivity and 100% specificity (95% CI)) if all four PCRs were positive/negative. The QF PCR method also achieved its greatest accuracy of 99.4% (100% sensitivity and 98.6% specificity (95% CI)) if all the measurements were positive/negative. Both real-time PCR and QF PCR were reliable methods for precisely assessing the fetalRHDallele from the plasma of RhD-negative pregnant women.
VytisknoutZobrazeno: 13. 5. 2024 02:27